🇺🇸 FDA
Patent

US 12005126

Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption

granted A61KA61K31/722A61K31/737

Quick answer

US patent 12005126 (Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption) held by ALMIRA PHARMA SRL expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ALMIRA PHARMA SRL
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/722, A61K31/737, A61K47/61, A61K47/6939